Global Amniotic Membrane Market Size Study, by Product, by Application, by End User and Regional Forecasts 2022-2032

Description

Global Amniotic Membrane Market is valued at approximately USD 1.02 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 9.26% over the forecast period 2024-2032. Amniotic membranes, derived from the innermost layer of the placenta, contain a unique combination of cells and extracellular matrix that endow them with regenerative properties. These membranes are increasingly utilized in various therapeutic practices due to their anti-inflammatory, anti-fibrotic, and anti-microbial properties, as well as their ability to support stem cell proliferation. They are predominantly used in ophthalmology, wound care, and surgical procedures. However, the market faces challenges such as ethical constraints, stringent regulations, and cost issues. Advances in preservation technologies, such as cryopreservation and lyophilization, are enhancing the storage and transport of these membranes, thereby expanding their availability and shelf-life. Increased awareness among healthcare professionals and patients about the benefits of amniotic membrane-based products is also creating opportunities for market expansion.

Cryopreserved amniotic membranes are highly valued for maintaining the tissue's inherent biological properties and structural integrity, ensuring their therapeutic effectiveness. Cryopreservation allows for long-term storage and viability of the tissue, making it readily available for various clinical applications. Lyophilized amniotic membranes, produced by dehydrating the tissue using freeze-drying, offer the advantage of stability at room temperature, facilitating storage and distribution without the need for refrigeration.

In ophthalmology, amniotic membranes are highly regarded for their therapeutic properties, which include promoting surface reconstruction, reducing inflammation, and inhibiting angiogenesis. These properties are particularly beneficial in surgeries involving the cornea, as they facilitate healing and support ocular surface restoration. In surgical wound care, amniotic membranes serve as biological dressings that assist with the natural healing process. Their use in various surgical applications, including burns, chronic wounds, and surgical incisions, is expanding.

Ambulatory Surgical Centers (ASCs) and hospitals are major end-users of amniotic membranes. ASCs utilize amniotic membranes for their healing properties, such as reducing inflammation and scarring and promoting re-epithelialization. Hospitals employ these membranes for a wide range of indications, including burns, difficult-to-heal wounds, and various surgical procedures where regenerative medicine is imperative. Research centers and laboratories are pivotal in exploring novel uses of amniotic membranes and enhancing the medical understanding of their regenerative properties.

The key regions considered for the global Amniotic Membrane Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the Amniotic Membrane Market in terms of revenue. The market growth in the region is being attributed to factors including strong presence of sophisticated healthcare infrastructure, heightened awareness amongst both practitioners and patients, and favorable reimbursement policies. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by rapidly advancing healthcare infrastructure, increasing investments in regenerative medicine, and an expansive patient population.

Major market players included in this report are:

MiMedx Group, Inc.
Smith & Nephew PLC
Integra LifeSciences Holdings Corporation
Organogenesis Holdings Inc.
Applied Biologics, LLC
BioStem Technologies, Inc.
Katena Products, Inc.
NuVision Biotherapies Ltd
Merakris Therapeutics
Lucina BioSciences, LLC
FzioMed Inc.
Genesis Biologics Inc.
Celularity Inc.
The Electrospinning Company
VIVEX Biologics, Inc.

The detailed segments and sub-segment of the market are explained below:

By Product:

Cryopreserved Amniotic Membrane
Lyophilization Amniotic Membrane

By Application:

Ophthalmology
Surgical Wound

By End User:

Ambulatory Surgical Center
Hospital
Research Centers Laboratory
Specialized Clinic

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Amniotic Membrane Market Executive Summary

1.1. Global Amniotic Membrane Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product
- 1.3.2. By Application
- 1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Amniotic Membrane Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Amniotic Membrane Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing Use in Ophthalmology and Surgical Applications
- 3.1.2. Advances in Preservation Technologies
- 3.1.3. Rising Awareness and Adoption of Regenerative Medicine
3.2. Market Challenges
- 3.2.1. Ethical and Regulatory Constraints
- 3.2.2. High Costs of Production and Storage
3.3. Market Opportunities
- 3.3.1. Expansion in Emerging Markets
- 3.3.2. Innovations in Product Innovation and Applications
- 3.3.3. Increasing Investments in Research and Development

Chapter 4. Global Amniotic Membrane Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Amniotic Membrane Market Size & Forecasts by Product 2022-2032

5.1. Segment Dashboard
5.2. Global Amniotic Membrane Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Cryopreserved Amniotic Membrane
- 5.2.2. Lyophilization Amniotic Membrane

Chapter 6. Global Amniotic Membrane Market Size & Forecasts by Application 2022-2032

6.1. Segment Dashboard
6.2. Global Amniotic Membrane Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Ophthalmology
- 6.2.2. Surgical Wound

Chapter 7. Global Amniotic Membrane Market Size & Forecasts by End User 2022-2032

7.1. Segment Dashboard
7.2. Global Amniotic Membrane Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Ambulatory Surgical Center
- 7.2.2. Hospital
- 7.2.3. Research Centers Laboratory
- 7.2.4. Specialized Clinic

Chapter 8. Global Amniotic Membrane Market Size & Forecasts by Region 2022-2032

8.1. North America Amniotic Membrane Market
- 8.1.1. U.S. Amniotic Membrane Market
  - 8.1.1.1. Product breakdown size & forecasts, 2022-2032
  - 8.1.1.2. Application breakdown size & forecasts, 2022-2032
  - 8.1.1.3. End User breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Amniotic Membrane Market
  - 8.1.2.1. Product breakdown size & forecasts, 2022-2032
  - 8.1.2.2. Application breakdown size & forecasts, 2022-2032
  - 8.1.2.3. End User breakdown size & forecasts, 2022-2032
8.2. Europe Amniotic Membrane Market
- 8.2.1. U.K. Amniotic Membrane Market
- 8.2.2. Germany Amniotic Membrane Market
- 8.2.3. France Amniotic Membrane Market
- 8.2.4. Spain Amniotic Membrane Market
- 8.2.5. Italy Amniotic Membrane Market
- 8.2.6. Rest of Europe Amniotic Membrane Market
8.3. Asia-Pacific Amniotic Membrane Market
- 8.3.1. China Amniotic Membrane Market
- 8.3.2. India Amniotic Membrane Market
- 8.3.3. Japan Amniotic Membrane Market
- 8.3.4. Australia Amniotic Membrane Market
- 8.3.5. South Korea Amniotic Membrane Market
- 8.3.6. Rest of Asia Pacific Amniotic Membrane Market
8.4. Latin America Amniotic Membrane Market
- 8.4.1. Brazil Amniotic Membrane Market
- 8.4.2. Mexico Amniotic Membrane Market
- 8.4.3. Rest of Latin America Amniotic Membrane Market
8.5. Middle East & Africa Amniotic Membrane Market
- 8.5.1. Saudi Arabia Amniotic Membrane Market
- 8.5.2. South Africa Amniotic Membrane Market
- 8.5.3. Rest of Middle East & Africa Amniotic Membrane Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Applied Biologics, LLC
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. BioStem Technologies, Inc.
- 9.3.3. Katena Products, Inc.
- 9.3.4. NuVision Biotherapies Ltd
- 9.3.5. Merakris Therapeutics
- 9.3.6. Lucina BioSciences, LLC
- 9.3.7. FzioMed Inc.
- 9.3.8. Genesis Biologics Inc.
- 9.3.9. Celularity Inc.
- 9.3.10. The Electrospinning Company
- 9.3.11. VIVEX Biologics, Inc.
- 9.3.12. MiMedx Group, Inc.
- 9.3.13. Smith & Nephew PLC
- 9.3.14. Integra LifeSciences Holdings Corporation
- 9.3.15. Organogenesis Holdings Inc.

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes